EZZ Stock Overview
EZZ Life Science Holdings Limited provides skin care and consumer health products in Australia, New Zealand, Mainland China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
EZZ Life Science Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.41 |
| 52 Week High | AU$0.44 |
| 52 Week Low | AU$0.28 |
| Beta | 0.57 |
| 1 Month Change | 10.81% |
| 3 Month Change | 17.14% |
| 1 Year Change | 1.23% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -64.66% |
Recent News & Updates
EZZ Life Science Holdings' (ASX:EZZ) Promising Earnings May Rest On Soft Foundations
Mar 06
Calculating The Fair Value Of EZZ Life Science Holdings Limited (ASX:EZZ)
Nov 22Shareholder Returns
| EZZ | AU Life Sciences | AU Market | |
|---|---|---|---|
| 7D | 2.5% | -2.3% | -0.03% |
| 1Y | 1.2% | -42.6% | -9.0% |
Return vs Industry: EZZ exceeded the Australian Life Sciences industry which returned -42.6% over the past year.
Return vs Market: EZZ exceeded the Australian Market which returned -9% over the past year.
Price Volatility
| EZZ volatility | |
|---|---|
| EZZ Average Weekly Movement | 9.6% |
| Life Sciences Industry Average Movement | 7.5% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in AU Market | 14.7% |
| 10% least volatile stocks in AU Market | 3.7% |
Stable Share Price: EZZ is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: EZZ's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Qizhou Qin | https://ezzlife.com.au |
EZZ Life Science Holdings Limited provides skin care and consumer health products in Australia, New Zealand, Mainland China, and internationally. The company operates in two segments, Brought in Lines and Company Owned products. It is involved in the wholesale distribution of EAORON branded skin care products to pharmacies, supermarkets, and specialist retailers, as well as grocery retailers.
EZZ Life Science Holdings Limited Fundamentals Summary
| EZZ fundamental statistics | |
|---|---|
| Market Cap | AU$17.08m |
| Earnings (TTM) | AU$2.51m |
| Revenue (TTM) | AU$23.93m |
7.0x
P/E Ratio0.7x
P/S RatioIs EZZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EZZ income statement (TTM) | |
|---|---|
| Revenue | AU$23.93m |
| Cost of Revenue | AU$8.26m |
| Gross Profit | AU$15.67m |
| Other Expenses | AU$13.16m |
| Earnings | AU$2.51m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.059 |
| Gross Margin | 65.49% |
| Net Profit Margin | 10.49% |
| Debt/Equity Ratio | 0% |
How did EZZ perform over the long term?
See historical performance and comparison